Response to recombinant human erythropoietin treatment in myelodysplastic syndromes (MDS)
Hast
R
R
Celsing
F
F
Ekman
M
M
Stenke
L
L
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin